Herbal asthma combo aims to stop chronic cough

NCT ID NCT07272278

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a Chinese herbal formula called Liqin Zhike to standard asthma inhalers (ICS/LABA) can reduce the chance of cough returning in people with cough variant asthma. About 236 adults aged 18 to 70 who are newly diagnosed will take either the inhaler alone or the inhaler plus the herbal formula. The main goal is to see if the combination lowers symptom recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Liqin Zhike Formula (Chinese herbal medicine) plus ICS/LABA inhaler
What this could lead to
If it works, this could offer a way to lower the chance of cough coming back in people with cough variant asthma.
What could go wrong
This is an early-stage study with no phase assigned, so results are uncertain. The herbal formula may not provide additional benefit over standard treatment, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.